Here, we show how TIM3 expression in breast cancer cells is a biomarker of poor outcome and high-risk of relapse in breast cancer (BC) patients and plays a unique role in MICs specific of micrometastasis, including survival, stemness, and immune-evasion. This evidence concerns the gene HAVCR2 and breast cancer.